LABFF vs LLY: Which Is the Better Dividend Stock?
As of June 2026, LABFF (Laboratorios Farmaceuticos Rovi, S.A.) screens as the stronger dividend stock, winning 4 of 7 head-to-head metrics. LABFF offers the higher yield at 23.77%, LLY has the higher dividend-safety score, and LABFF trades at the larger discount to fair value (-1%).
| Metric | LABFF | LLY |
|---|---|---|
| Forward yield | 23.77% | 0.61% |
| Annual dividend | $21.54 | $6.92 |
| Payout ratio | 0% | 22% |
| Years of growth | 0 yr | 11 yr |
| 5-yr dividend growth | — | 15.2% |
| 5-yr total return | 34% | 351% |
| Dividend safety score | 42 (D) | 94 (A) |
| Fair value estimate | $89.89 | $992.40 |
| Upside to fair value | -1% | -10% |
| Frequency | monthly | quarterly |
| Market cap | $4.6B | $1.0T |
| P/E ratio | 28.9 | 40.0 |
Higher yield
LABFF
23.77%
Safer dividend
LLY
Grade A
Faster growth
LLY
15.2%
Better value
LABFF
-1% upside
LABFF vs LLY — FAQ
Related comparisons
See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.